EXPERIENCE ON MASS IMMUNIZATION OF HUMAN BEINGS WITH THE M-44 LIVE VACCINE AGAINST Q-FEVER. REPORT 2. SKIN AND ORAL ROUTES OF IMMUNIZATION

Abstract

With cutaneous application the live M-44 Q-fever vaccine turned out to be mildly reactogenic. The symptoms of a general reaction were weakly expressed and observed rarely (1.3%). Based on immunological effectiveness the cutaneous method of vaccination with the live M-44 vaccine in the corresponding vaccine dose is not inferior to the subcutaneous method. Along with this it is a simpler method of immunization and this makes it possible to recommend the cutaneous live Q-fever vaccine for practical utilization in the mass inoculation of threatened contingents. Carrying out the mass immunization of human beings with the live Q-fever vaccine is possible without the preliminary selection based on serum immunological reactions. The results of the tests carried out on the harmlessness and immunological effectiveness of the live vaccine when it is administered by the oral route testify to the favorable outlook for putting into practice the oral application of the live Q-fever vaccine.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 1966
Accession Number
AD0815217

Entities

People

  • V. A. Genig

Organizations

  • United States Army Biological Warfare Laboratories

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Animals
  • Antibodies
  • Biological Laboratories
  • Commerce
  • Dilution
  • Experimental Data
  • Export Controls
  • Immunization
  • Inoculation
  • Laboratory Animals
  • Lymph Nodes
  • Lymphatic System
  • Observation
  • Q Fever
  • Rodents
  • Russian Language
  • Vaccination

Readers

  • Immunology
  • Systems Analysis and Design

Technology Areas

  • Biotechnology